USPTO serial 87935255
CATALYST PATHWAYS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 2, 2021
- Examiner
- ADORNO SANTOS, LUZ M.
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with CATALYST PATHWAYS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Catalyst Pharmaceuticals, Inc.
Coral Gables, FL, US
Catalyst Pharmaceuticals, Inc.
Coral Gables, FL, US
Catalyst Pharmaceuticals, Inc.
Coral Gables, FL, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Peter A. Chiabotti
Peter A. Chiabotti AKERMAN LLP777 South Flagler DriveSuite 1100, West TowerWEST PALM BEACH, FL 33401Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Providing billing information and medical billing support services to patients and healthcare professionals; administering pharmacy reimbursement programs and services for business purposes; providing physician's offices with commercial information, input and guidance on navigating the prior approval process for pharmaceutical products | ACTIVE | Jan 25, 2019 |
| 036 | Providing health insurance information about health insurance benefits to patients and healthcare professionals; financial consultation to medical patients in obtaining reimbursement of health care costs and identification of health insurance alternatives | ACTIVE | Jan 25, 2019 |
| 044 | Medical patient support services, namely, providing information relating to the therapeutic properties of pharmaceuticals, providing information relating to healthcare, disease management, and pharmaceutical dosing and safety information to patients and healthcare professionals | ACTIVE | Jan 25, 2019 |
| 045 | Assisting patients by coordinating with patients, pharmacies, payors, and physician offices in healthcare benefits' investigation, verification and pharmaceutical prescriptions and refills and locating support programs to aid in out of pocket healthcare costs, namely, third-party charitable foundations, company-sponsored charity care, and copay-assistance programs for commercially insured patients | ACTIVE | Jan 25, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Catalyst Pharmaceuticals, Inc.
- Other trademarks owned by Catalyst Pharmaceuticals, Inc.
- Other trademarks owned by Catalyst Pharmaceuticals, Inc.
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named CATALYST PATHWAYS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 29, 2026 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| May 29, 2026 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| May 29, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 9, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Mar 2, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 2, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 27, 2021 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jan 26, 2021 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jan 6, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 6, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 29, 2020 | ALIE | ASSIGNED TO LIE | — |
| Dec 28, 2020 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Dec 18, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 7, 2020 | IUAF | USE AMENDMENT FILED | — |
| Dec 7, 2020 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 23, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 2, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 30, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 30, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 30, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 31, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 5, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 5, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 16, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 30, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 12, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 12, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 12, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 12, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 27, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 26, 2019 | ALIE | ASSIGNED TO LIE | — |
| Aug 26, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 26, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 26, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 3, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 2, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 2, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 3, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 3, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 3, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 29, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 28, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 28, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 20, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 20, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 20, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 2, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 28, 2018 | NWAP | NEW APPLICATION ENTERED | — |